Cargando…
Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type
SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) protein is the target for the antiviral drug Remdesivir (RDV). With RDV clinical trials on COVID-19 patients showing a reduced hospitalisation time. During the spread of the virus, the RdRp has developed several mutations, with the most frequent being A...
Autores principales: | Mohammad, Anwar, Al-Mulla, Fahd, Wei, Dong-Qing, Abubaker, Jehad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301449/ https://www.ncbi.nlm.nih.gov/pubmed/34206274 http://dx.doi.org/10.3390/biom11070919 |
Ejemplares similares
-
Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity
por: Mohammad, Anwar, et al.
Publicado: (2021) -
Effects of the RNA-Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers—An MD Study
por: Bringas, Mauro, et al.
Publicado: (2022) -
Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination
por: Hasan, Amal, et al.
Publicado: (2021) -
Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity
por: Mohammad, Anwar, et al.
Publicado: (2021) -
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
por: Tchesnokov, Egor P., et al.
Publicado: (2019)